$992KRound, 27 October 2025
Lithea raised SEK 9.3M (about €850K) from existing investors to prepare its doxorubicin pellet LIT1001 for osteosarcoma for clinical trials.
- Amount
- $992K
- Announced
- 27 October 2025
- Lead
- Existing investors
- Use of funds
- Lithea raised SEK 9.3M (about €850K) from existing investors to prepare its doxorubicin pellet LIT1001 for osteosarcoma for clinical trials.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Lithea raises 852K euros for localised cancer therapy eu-startups.com
Lithea raises 852K euros for localised cancer therapy arcticstartup.com